lumigan 0.1 mg/ml, collyre en solution
abbvie ag - bimatoprostum - 0.1 mg/ml, collyre en solution - bimatoprostum 0.1 mg, benzalkonii chloridum 200 µg, dinatrii phosphas heptahydricus corresp. phosphas 0.95 mg, acidum citricum monohydricum, natrii chloridum, acidum hydrochloridum aut natrii hydroxidum ad ph, aqua purificata, ad solutionem pro 1 ml. - le glaucome - synthetika
lumigan 0,3 mg/ml unit dose collyre
abbvie ag - bimatoprostum - collyre - bimatoprostum 0.3 mg, dinatrii phosphas heptahydricus corresp. phosphas 0.95 mg, acidum citricum monohydricum, natrii chloridum, acidum hydrochloridum aut natrii hydroxidum ad ph, aqua purificata, ad solutionem pro 1 ml. - le glaucome - synthetika
lumigan
abbvie deutschland gmbh & co. kg - bimatoprost - glaucoma, open-angle; ocular hypertension - prostaglandin analogues, ophthalmologicals - réduction de la pression intraoculaire élevée dans le glaucome à angle ouvert chronique et l'hypertension oculaire (en monothérapie ou en traitement d'appoint aux bêta-bloquants).
vistitan solution
sandoz canada incorporated - bimatoprost - solution - 0.03% - bimatoprost 0.03% - prostaglandin analogs
lumigan pf solution
allergan inc - bimatoprost - solution - 0.03% - bimatoprost 0.03% - prostaglandin analogs
lumigan solution
allergan inc - bimatoprost - solution - 0.03% - bimatoprost 0.03% - prostaglandin analogs
lumigan rc solution
abbvie corporation - bimatoprost - solution - 0.01% - bimatoprost 0.01% - prostaglandin analogs
latisse solution
abbvie corporation - bimatoprost - solution - 0.03% - bimatoprost 0.03% - prostaglandin analogs
zimed pf solution
aequus pharmaceuticals inc. - bimatoprost - solution - 0.03% - bimatoprost 0.03%
elymbus 0.1 mg/g gel ophtalmique
thea pharma s.a. - bimatoprostum - gel ophtalmique - bimatoprostum 0.1 mg, sorbitolum, carbomerum 974p, natrii acetas trihydricus, macrogolum 4000, natrii hydroxidum ad ph, aqua ad iniectabile q.s. ad gelatum pro 1 g. - glaucome à angle ouvert, hypertension oculaire - synthetika